Brallobarbital

Jump to navigation Jump to search
Brallobarbital
File:Brallobarbital.png
Clinical data
SynonymsBrallobarbital, Vesparax
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H11BrN2O3
Molar mass287.11 g/mol

Brallobarbital (Vesparax) is a barbiturate derivative invented in 1964. It has sedative and hypnotic properties, and was used for the treatment of insomnia. Brallobarbital was primarily sold as part of a combination product called Vesparax, composed of 150 mg secobarbital, 50 mg brallobarbital and 50 mg hydroxyzine.[1] The long half-life of this combination of drugs tended to cause a hangover effect the next day,[2] and Vesparax fell into disuse once newer drugs with less side effects had been developed.[3]


References

  1. Lhermann J. Clinical application of a new very active hypnotic associating sodium secobarbital, calcium brallobarbital and hydroxyzine (UC-8130). Gazette Medicale de France. 1964 Mar 10;71:961-2. (French)
  2. Yih TD, Rossum JM. Peculiar pharmacokinetics of brallobarbital as a source of complications in Vesparax intoxication. Xenobiotica. 1976 Jun;6(6):355-62.
  3. Fischbach R. Efficacy and safety of midazolam and vesparax in treatment of sleep disorders. British Journal of Clinical Pharmacology. 1983;16 Suppl 1:167S-171S.

Template:Pharma-stub

Template:Barbiturates

fi:Brallobarbitaali